Effect of dairy products fortified with vitamin d3 on restless legs syndrome in women with premenstrual syndrome, abdominal obesity and vitamin d deficiency: a pilot study.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The researchers aimed to evaluate the effect of dairy products fortified with Vitamin D3 on RLS in women with PMS.

Why It Was Studied

Restless legs syndrome (RLS) is an unpleasant condition that affects the quality of life of patients.

Vitamin D plays a key role in female reproduction through its impact on calcium homeostasis and neurotransmitters.

Who Took Part

PubMed indexes the participants as adults and middle-aged adults, women only.

Among 141 middle-aged women with abdominal obesity, 71 and 70 cases received fortified and non-fortified low-fat dairy products, respectively.

All subjects completed a Symptoms Screening Tool (PSST) and RLS questionnaires.

How the Study Was Run

The researchers set it up as a randomized and pilot study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

What Was Measured

The subject headings attached to it are Cholecalciferol, Dairy Products, Food, Fortified, Obesity, Abdominal, Pilot Projects, Premenstrual Syndrome and Restless Legs Syndrome.

Author keywords: Fortification, Low-fat dairy and Vitamin D.

What This Means in Plain Language

The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (BMC women's health), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.